Finding a Cure for Cancer with Mistletoe? Believe Big Is Helping To Kiss Cancer Goodbye

Through the extraordinary fundraising efforts of a small Baltimore non-profit, Believe Big, Johns Hopkins Hospital is preparing to begin a clinical trial on mistletoe extract to help find a cure for cancer.

Baltimore, MD (PRWEB) February 04, 2014

Mistletoe therapy is used widely in Germany and Switzerland for cancer treatment. However, until a clinical trial is done here in the United States, it cannot be offered to patients as standard of care. Studies in Europe have shown that mistletoe treatments along with a high alkaline diet are key components that can aid the body when fighting and overcoming cancer. The liquid extract of the mistletoe plant has been used as an alternative method to treat cancer for close to a century. Mistletoe injections are among the most widely used unconventional cancer treatments in Europe. In Europe, the most common commercial preparations are sold under the trade names Iscador and Helixor. Currently, only the European species of the mistletoe plant is used for cancer.

Believe Big founder, Ivelisse Page, was cured of her stage 4 colon cancer by using mistletoe extract and a high alkaline diet. She is now 5 years cancer free. Clinical trials are typically funded by pharmaceutical companies but mistletoe is natural, so this is not an option. This is truly an historic event because this clinical trial is patient driven and is being entirely funded by private donations. Currently only 50 Anthroposophic physicians are trained to treat with mistletoe in the U.S.

“We have 90% of the money needed to start Phase I of the trial. We are thrilled to be taking the first steps towards a cure for this devastating disease,” said Patty Buddemeyer, Assistant Director of Believe Big.

European oncologists have used extracts of mistletoe for the past 90 years. One study showed that individuals who took mistletoe extract in addition to their conventional treatment lived 40% longer. Currently, 1 out of every 3 oncologists in Germany prescribes mistletoe. Not only has mistletoe been found to diminish tumor-related pain, increase the immune response, prevent re-occurrence during the watchful waiting period, but it also offsets the terrible side affects of chemotherapy—nausea, vomiting, and lack of appetite.

Believe Big is a non-profit organization formed in 2011 to help families navigate the cancer journey by providing resources, direction and hope. Now Believe Big and Johns Hopkins are collaborating on a mistletoe clinical trial that brings the conventional and complimentary medical communities together. Johns Hopkins researchers say mistletoe treatment can change the way doctors go after cancer.

Dr. Luis Diaz, professor of oncology and senior researcher at Johns Hopkins, and Dr. Peter Hinderberger, expert in complementary medicine, both treated Ivelisse and are leading the clinical trial at Johns Hopkins. Dr. Hinderberger has used mistletoe in his practice successfully for over three decades. The clinical trial team is hoping that with this study, mistletoe will be included in the standard of care treatment protocol for cancer.

For more information about Believe Big and to find an Anthroposophic physician who is currently treating with mistletoe, visit http://www.believebig.org. Anyone wishing to be a part of this historic event can make a tax deductible donation for this trial by visiting http://www.gofundme.com/believebig-mistletoeTrial.


Contact

Attachments